Bioelectrix
1 known investors
Bioelectrix develops patented wound electrodes that deliver gentle direct current to reactivate stalled healing while capturing real-time healing data, aiming to accelerate closure of hard-to-heal wounds. Its bioelectronic wound therapy initially targets diabetic foot ulcers and is intended for clinicians, payers, and existing healthcare wound care workflows.
BiotechDigital HealthMedical Devices